Registry for patients with fibrotic interstitial lung disease in Taiwan
A Prospective Multi-center Registry for Fibrotic Lung Disease, Focusing on Clinical Phenotype, Physical Parameters, Image Analysis, and Precision Medicine in Taiwan
This study is collecting health information from patients with fibrotic interstitial lung disease in Taiwan to see how they do over time and how well different treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Taichung Veterans General Hospital Academic / other |
| Locations | 1 site (Taichung) |
| Trial ID | NCT06476470 on ClinicalTrials.gov |
What this trial studies
This observational registry aims to evaluate the long-term outcomes of patients diagnosed with fibrotic interstitial lung disease (ILD) in Taiwan. It will collect comprehensive clinical data from multiple centers, including epidemiological information, comorbidities, and various tests such as pulmonary function tests and echocardiograms, all following a standardized protocol. Key components include annual high-resolution computed tomography (HRCT) scans and cardiopulmonary exercise tests (CPET), along with biobank blood samples. The registry seeks to answer critical questions regarding mortality differences among ILD patients and the effectiveness of anti-fibrotic drugs.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults over 18 years old diagnosed with various forms of interstitial lung disease.
Not a fit: Patients under 18 years of age or those unable to provide informed consent will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the long-term management and treatment outcomes for patients with fibrotic interstitial lung disease.
How similar studies have performed: Other studies have shown success in similar observational approaches, indicating the potential for valuable data collection and insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Aged over 18 years old. 2. Diagnosed as ILD by a pulmonologist, rheumatologist or radiologist 3. Various casue of ILD, including Idiopathic pulmonary fibrosis (IPF), Connective tissue disease-associated interstitial lung disease (CTD-ILD), Unclassifed ILD, drug-induced ILD, lymphangioleiomyomatosis (LAM), and sarcoidosis-associated ILD. Exclusion Criteria: 1. Under 18 years of age. 2. Failure to express informed consent in person.
Where this trial is running
Taichung
- Taichung Veterans General Hospital — Taichung, Taiwan (Recruiting)
Study contacts
- Principal investigator: Pin-Kuei Fu, MD., Ph.D — Taichung Veterans General Hospital
- Study coordinator: Pin-Kuei Fu, MD., Ph.D
- Email: yetquen@gmail.com
- Phone: 04-23592525
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.